Buy Evista from Discount Pharmacy
We are a leading Canadian mail-order pharmacy service focusing on both on prescription cost-containment and patient safety. We only work with a small network of trusted and reputable international pharmacies and fulfillment centers, giving you access to authentic medications at low prices every day. All medications are shipped directly to you from our affiliated licensed international and Canadian pharmacies and fulfillment centers. Our staff are knowledgeable and efficient to ensure that your shopping experience is hassle free. Save on prescription drugs like Evista as well as other prescription drugs like Avodart, Celebrex, Diovan, Gleevec, Neurontin, Plavix, Prevacid, Levitra, Viagra, Zoloft.
10 Great Reasons to Choose Our Service!
Your Evista are shipped in sealed drug manufacturer's containers from the licensed pharmacy.
Safe, confidential, and experienced Canadian prescription service provided by licensed Canadian pharmacists and technicians.
All prescription orders come with a unique tracking number from our fulfillment partner.
Live, friendly, and knowledgeable customer service helping you order your prescription.
The exchange rate between the American currency and Canadian dollar allows American more spending power when buying from Canada.
A licensed and accredited pharmacy will dispense and fill your prescription drugs from your chosen pharmacy.
Our Canadian Pharmacy offers convenient payment by VISA, Master Card or international money order.
The Canadian government regulates the price of prescription drugs in Canada so you can save hundreds of dollars per year.
You can save even more when you order generic drugs. Canadian generic prescriptions drugs are the exact same quality and potency as brand name prescriptions drugs, but cost less.
No hidden fees. All you pay is the cost of Evista prescription drugs plus a shipping fee.
Why Are Cancer Drugs So Expensive?
The high cost of cancer drugs is related to a number of factors. It is very very expensive to move findings from bench to bedside and to perform all the regulatory studies (from phase 1, 2, and 3 clinical trials) to gain approval. Second, even when the monopoly is broken with the arrival of 'new and improved' versions of an approved drug, the older drug (and by now generic) tends to be viewed as substandard treatment, thereby perpetuating the situation. Third, the very nature of cancer, and the seriousness of the diagnosis, plays a role in that patients and physicians are often willing to pay the high price of treatment even for marginal improvements in outcome. Finally, because most cancers are incurable, patients are treated with each approved agent creating a virtual monopoly because the use of one drug does not automatically mean that the others are no longer needed.